About: A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 07 July 2011

AttributesValues
rdf:type
description
  • videnskabelig artikel (da)
  • article científic (ca)
  • articolo scientifico (it)
  • artigo científico (pt)
  • bilimsel makale (tr)
  • vedecký článok (sk)
  • vetenskaplig artikel (sv)
  • vědecký článek (cs)
  • wetenschappelijk artikel (nl)
  • wissenschaftlicher Artikel (de)
  • научни чланак (sr)
  • article scientifique (fr)
  • artículu científicu espublizáu en 2011 (ast)
  • наукова стаття, опублікована в липні 2011 (uk)
  • مقالة علمية نشرت في 07 يوليو 2011 (ar)
  • scientific article published on 07 July 2011 (en)
publication date
publication date
language of work or name
language of work or name
cites work
cites work
author name string
author name string
  • Amit Verma
  • Samir Parekh
  • John Schindler
  • Yumin Shen
  • Ira Braunchweig
  • Srikanth Gajavelli
  • Stefan Barta
rdfs:label
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (nl)
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia (en)
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia (ast)
skos:prefLabel
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (nl)
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia (en)
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia (ast)
name
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (nl)
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia (en)
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia (ast)
author
author
title
title
  • A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia (en)
page(s)
page(s)
  • 471-476
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 21732928
published in
published in
issue
volume
issue
  • 4
volume
  • 154
DOI
DOI
DOI
  • 10.1111/J.1365-2141.2011.08762.X
ResearchGate publication ID
ResearchGate publication ID
  • 51470911
PMCID
PMCID
  • 3877839
is about of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software